| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.48B | -5.2% |
| Cost of Revenue | $196.5M | -19.9% |
| R&D Expense | $324.0M | +32.1% |
| SG&A Expense | $701.5M | +8.7% |
| Operating Income | $254.0M | -39.6% |
| Pre-tax Income | $291.4M | -34.3% |
| Income Tax | $49.8M | -30.5% |
| Net Income | $241.7M | -34.2% |
| EPS (Basic) | $1.47 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $388.6M | +33.5% |
| Accounts Receivable | $334.0M | -13.1% |
| Inventory | $196.6M | +7.5% |
| Current Assets | $1.93B | +36.3% |
| Total Assets | $2.49B | +21.0% |
| Current Liabilities | $543.4M | +16.8% |
| Total Liabilities | $667.7M | +13.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $520.8M | +18.6% |
| Capital Expenditures | $40.4M | +20.7% |
| Investing Cash Flow | $295.5M | +365.5% |
| Financing Cash Flow | $12.4M | +102.5% |
| Free Cash Flow | $480.3M | +18.4% |
| -33.8% |
| EPS (Diluted) | $1.43 | -34.1% |
| Stockholders' Equity |
| $1.82B |
| +24.2% |